The Fair Trade Commission announced Tuesday that it was tentatively disapproving the proposed takeover of CJ HelloVision by SK Telecom.
After reviewing the proposal over the last seven months, the antitrust agency issued its ban order stressing that the takeover would limit competition in the market.
The antitrust watchdog sent its review to SKT the previous day. The disapproval came as a rare move by the FTC, which endorses or conditionally approves proposals in most cases.
The FTC said if the takeover had been approved, SKT and CJH would have their broadcasting business dominate 21 out of 23 regions in the domestic market, establishing dominance.
Expectations are that SK Telecom will fiercely argue over the properness of its merger proposal with the antitrust agency at the scheduled full session to catch its last chance to resuscitate its drive.
Following the decision, SKT will submit an appeal to a full session of the FTC, scheduled to be held around July 20. At the meeting, standing members of the FTC will make a final decision on the proposal.
Based on the FTC’s opinion, the Ministry of Science, ICT and Future Planning will make its final decision on the issue in consultation with the Korea Communications Commission.
Full Content: Korea Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas